Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2022 Mar 3;12:3550. doi: 10.1038/s41598-022-07626-1

Short-term smoking increases the risk of insulin resistance

Soo Hyeon Cho 1,#, Sung Hoon Jeong 1,2,#, Jaeyong Shin 2,3, Sohee Park 2,4, Sung-In Jang 2,3,✉
PMCID: PMC8894492  PMID: 35241770

Abstract

Insulin resistance can be affected directly or indirectly by smoking. This cross-sectional study aimed at examining the association between smoking patterns and insulin resistance using objective biomarkers. Data from 4043 participants sourced from the Korea National Health and Nutrition Examination Survey, conducted from 2016 to 2018, were examined. Short-term smoking patterns were used to classify participants according to urine levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and cotinine as continuous-smokers, past-smokers, current-smokers, and non-smokers. Insulin resistance was calculated using the triglyceride-glucose index from blood samples and was defined as either high or low. Multiple logistic regression analysis was performed to investigate the association between smoking behavior and insulin resistance. Men and women who were continuous-smokers (men: odds ratio [OR] = 1.74, p = 0.001; women: OR = 2.01, p = 0.001) and past-smokers (men: OR = 1.47, p = 0.033; women: OR = 1.37, p = 0.050) were more likely to have high insulin resistance than their non-smoking counterparts. Long-term smokers (≥ 40 days) are at an increased risk of insulin resistance in short-term smoking patterns. Smoking cessation may protect against insulin resistance. Therefore, first-time smokers should be educated about the health benefits of quitting smoking.

Subject terms: Biomarkers, Diseases, Endocrinology, Health care, Health occupations

Introduction

Insulin resistance is a growing metabolic disorder worldwide and is associated with some of the most common diseases affecting the modern society, including diabetes, high blood pressure, obesity, and coronary heart disease1. Direct methods of assessing insulin resistance include euglycemic-hyperinsulinemia clamp and insulin suppression tests and simple indirect indicators are estimated by the homeostasis model assessment of insulin resistance (HOMA-IR)2–4. However, these tests are invasive, complex, and expensive, making their application difficult in large-scale population studies and clinical practice5. Recently, the triglyceride and glucose (TyG) index, a simple and accurate marker of insulin resistance, has been proposed, which uses fasting triglyceride and blood glucose levels for calculation6. The TyG index can help screen people at high risk of diabetes mellitus with a simple blood test. Furthermore, studies using the TyG index in adults in the Republic of Korea showed that an increase in the TyG index was associated with an increase in the prevalence of coronary artery calcification or arterial stiffness7,8 and suggested that it is a useful tool for evaluating insulin resistance6.

Smoking is a lifestyle factor that may directly or indirectly affect insulin resistance9. Several prospective studies on the relationship between smoking and insulin resistance have shown that smoking is a risk factor for insulin resistance10–13. However, these studies have mostly used self-reporting as a method of measuring exposure to smoking, and this may have led to incorrect measurement, as self-reported and biomarker results show a consistency of only 46–53%; in addition, self-reports tend to be unreliable for quantitative assessments of smoking volume14,15. These findings suggest that an objective method of measuring smoking volume is required to account for the inherent bias in self-reported data.

Cotinine is the main metabolite of nicotine present in the blood, urine, hair, and saliva and is considered an indicator of exposure to nicotine smoke or current smoking16. While nicotine has a half-life of around 2 h in the blood, cotinine has a half-life of 18–24 h and reflects the accumulated exposure to environmental tobacco smoke17. In particular, urine cotinine levels may help determine the contribution of smoke in the air during the sampling process to the total smoking exposure18. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNAL) has been used extensively to assess the accuracy of self-reported smoking status19,20. NNAL is widely known as a biomarker of nicotine-derived nitrosamine ketone, a tobacco-specific lung carcinogen21,22. Furthermore, NNAL, due to its half-life of approximately 40 days, is useful for its tobacco specificity, association with carcinogen intake, facilitation of consistent detection of people exposed to tobacco, and evaluation of long-term exposure to harmful substances23.

Identifying an association between cotinine and NNAL, objective biomarkers of tobacco exposure, and insulin resistance may help assess the effect of smoking on the risk of insulin resistance. Although several studies based on self-reported data have been published regarding the influence of smoking on the risk of insulin resistance, to the best of our knowledge, no studies have examined this effect using objective smoking-related biomarkers. Therefore, this study investigated the relationship between smoking patterns and insulin resistance using cotinine and NNAL as biomarkers of tobacco exposure.

Results

Demographic characteristics

Of 4,043 participants, 2,067 (51.1%) were males (Table 1). Of the 2,067 male participants, 839 (40.6%), 454 (22.0%), 12 (0.6%), and 762 (36.9%) were continuous-smokers, past-smokers, current-smokers, and non-smokers, respectively. Of the 1976 (48.9%) female participants, 201 (10.2%), 452 (22.9%), 22 (1.1%), and 1301 (65.8%) were continuous-smokers, past-smokers, current-smokers, and non-smokers, respectively. The insulin resistance groups differed with respect to all factors except educational levels, household income, region, occupational categories, energy intake levels, secondhand smoking exposure, and the survey year.

Table 1.

General characteristics of the study population.

Variables Triglycerides and glucose index
Total Men Total Women
Low IR Group (%) High IR Group (%) P value Low IR Group (%) High IR Group (%) P value
N % N % N % N % N % N %
Total 2067 100.0 610 29.5 1457 70.49 1976 100.0 1276 64.6 700 35.43
Short-term smoking pattern 0.0003 0.0132
 Continuous-smoker 839 40.6 206 33.8 633 43.4 201 10.2 112 8.8 89 12.7
 Past-smoker 454 22.0 140 23.0 314 21.6 452 22.9 285 22.3 167 23.9
 Current-smoker 12 0.6 3 0.5 9 0.6 22 1.1 12 0.9 10 1.4
 Non-smoker 762 36.9 261 42.8 501 34.4 1301 65.8 867 67.9 434 62.0
Age  < 0.0001  < 0.0001
 19–29 386 18.7 172 28.2 214 14.7 323 16.3 277 21.7 46 6.6
 30–39 410 19.8 123 20.2 287 19.7 347 17.6 258 20.2 89 12.7
 40–49 412 19.9 83 13.6 329 22.6 351 17.8 226 17.7 125 17.9
 50–59 352 17.0 78 12.8 274 18.8 399 20.2 232 18.2 167 23.9
 60–69 316 15.3 91 14.9 225 15.4 321 16.2 173 13.6 148 21.1
  ≥ 70 191 9.2 63 10.3 128 8.8 235 11.9 110 8.6 125 17.9
Marital Status  < 0.0001 0.0035
 Married 1315 63.6 332 54.4 983 67.5 1245 63.0 774 60.7 471 67.3
 Single. widow, divorced, separated 752 36.4 278 45.6 474 32.5 731 37.0 502 39.3 229 32.7
Educational level 0.1166  < 0.0001
 Middle school or below 380 18.4 105 17.2 275 18.9 598 30.3 308 24.1 290 41.4
 High school 810 39.2 260 42.6 550 37.7 701 35.5 457 35.8 244 34.9
 College or over 877 42.4 245 40.2 632 43.4 677 34.3 511 40.0 166 23.7
Household income 0.3308  < 0.0001
 Low 290 14.0 97 15.9 193 13.2 356 18.0 187 14.7 169 24.1
 Mid-low 490 23.7 147 24.1 343 23.5 505 25.6 321 25.2 184 26.3
 Mid-high 618 29.9 170 27.9 448 30.7 563 28.5 375 29.4 188 26.9
 High 669 32.4 196 32.1 473 32.5 552 27.9 393 30.8 159 22.7
Region 0.9638 0.5051
 Urban area 1710 82.7 505 82.8 1205 82.7 1616 81.8 1049 82.2 567 81.0
 Rural area 357 17.3 105 17.2 252 17.3 360 18.2 227 17.8 133 19.0
Occupational categoriesa 0.1170  < 0.0001
 White 634 30.7 171 28.0 463 31.8 450 22.8 329 25.8 121 17.3
 Pink 224 10.8 58 9.5 166 11.4 338 17.1 230 18.0 108 15.4
 Blue 693 33.5 215 35.2 478 32.8 315 15.9 180 14.1 135 19.3
 Inoccupation 516 25.0 166 27.2 350 24.0 873 44.2 537 42.1 336 48.0
BMIb  < 0.0001  < 0.0001
 Underweight or Normal (< 25) 1253 60.6 460 75.4 793 54.4 1433 72.5 1038 81.3 395 56.4
 Overweight(≥ 25.0) 814 39.4 150 24.6 664 45.6 543 27.5 238 18.7 305 43.6
Drinking status 0.0072 0.0040
 No 284 13.7 103 16.9 181 12.4 609 30.8 365 28.6 244 34.9
 Yes 1783 86.3 507 83.1 1276 87.6 1367 69.2 911 71.4 456 65.1
Walking frequentlyc 0.0071 0.0044
 Inadequate 1023 49.5 274 44.9 749 51.4 1135 57.4 703 55.1 432 61.7
 Adequate 1044 50.5 336 55.1 708 48.6 841 42.6 573 44.9 268 38.3
Energy intake leveld 0.1847 0.8166
 Inadequate 1242 60.1 380 62.3 862 59.2 1340 67.8 863 67.6 477 68.1
 Adequate 825 39.9 230 37.7 595 40.8 636 32.2 413 32.4 223 31.9
Chronic disease diagnosise  < 0.0001  < 0.0001
 No 1570 76.0 499 81.8 1071 73.5 1457 73.7 1033 81.0 424 60.6
 Yes 497 24.0 111 18.2 386 26.5 519 26.3 243 19.0 276 39.4
Secondhand smoke exposure 0.2078 0.1218
 No 1354 65.5 412 67.5 942 64.7 1461 73.9 929 72.8 532 76.0
 Yes 713 34.5 198 32.5 515 35.3 515 26.1 347 27.2 168 24.0
Family historyf 0.0046 0.0510
 No 1630 78.9 505 82.8 1125 77.2 1501 76.0 987 77.4 514 73.4
 Yes 437 21.1 105 17.2 332 22.8 475 24.0 289 22.6 186 26.6
Pack-Year of Smoking  < 0.0001 0.0307
 Pack-Years < 10 1150 55.6 402 65.9 748 51.3 1962 99.3 1248 97.8 670 95.7
 10 ≤ Pack-Years < 20 374 18.1 79 13.0 295 20.2 42 2.1 20 1.6 22 3.1
  ≥ 20 543 26.3 129 21.1 414 28.4 16 0.8 8 0.6 8 1.1
Year 0.6854 0.8881
 2016 727 35.2 207 33.9 520 35.7 801 40.5 518 40.6 283 40.4
 2017 650 31.4 192 31.5 458 31.4 544 27.5 347 27.2 197 28.1
 2018 690 33.4 211 34.6 479 32.9 631 31.9 411 32.2 220 31.4
Open in a new tab

IR, insulin resistance.

aThree groups (white, pink, and blue) based on the International Standard Classification of Occupations codes. The inoccupation group includes homemakers.

bBMI: body mass index; obesity status was defined based on BMI according to the 2018 Clinical Practice Guidelines for Overweight and Obesity in Korea.

cWalking frequency was based on the recommended walking activity according to the physical activity guidelines in Korea.

dEnergy intake was classified according to the Korean Nutrient Intake Criteria (2015) provided by the Ministry of Health and Welfare.

eChronic disease was defined as a diagnosed disease, such as hypertension and dyslipidemia.

fFamily history of diabetes was defined as having an immediate family member (e.g., father, mother, brother, and/or sister) with diabetes.

Association between smoking patterns and insulin resistance

Table 2 presents the associations between smoking patterns and insulin resistance for male and female participants after adjusting for all control variables. Compared to non-smokers, men who were continuous-smokers (odds ratio [OR] = 1.74, 95% confidence interval [CI] = 1.27–2.38) and past-smokers (OR = 1.47, 95% CI = 1.03–2.09) were at an increased risk of insulin resistance. Similarly, compared to non-smokers, women who were continuous-smokers (OR = 2.01, 95% CI = 1.33–3.03) and past-smokers (OR = 1.37, 95% CI = 1.00–1.87) were at an increased risk of insulin resistance.

Table 2.

Association between short-term smoking patterns and the triglyceride and glucose index.

Variables High IR
Men Women
Adjusted OR 95% CI p value Adjusted OR 95% CI p value
Short-term smoking pattern
 Continuous-smoker 1.74 1.27–2.38 0.001 2.01 1.33–3.03 0.001
 Past-smoker 1.47 1.03–2.09 0.033 1.37 1.00–1.87 0.050
 Current-smoker 1.06 0.20–5.56 0.949 0.90 0.29–2.78 0.850
 Non-smoker 1.00 1.00
Age
 19–29 1.00 1.00
 30–39 1.78 1.18–2.68 0.006 1.90 1.09–3.32 0.024
 40–49 2.61 1.61–4.24  < 0.0001 2.60 1.52–4.43 0.000
 50–59 2.54 1.44–4.46 0.001 3.92 2.26–6.78  < 0.0001
 60–69 1.91 1.05–3.47 0.035 3.46 1.85–6.47  < 0.0001
  ≥ 70 1.27 0.65–2.48 0.493 4.30 2.13–8.70  < 0.0001
Marital Status
 Married 1.00 1.00
 Single. widow, divorced, separated 0.81 0.58–1.14 0.221 0.84 0.60–1.16 0.284
Educational level
 Middle school or below 1.00 1.00
 High school 0.76 0.49–1.17 0.209 1.02 0.71–1.45 0.927
 College or over 0.80 0.50–1.27 0.347 0.91 0.60–1.37 0.637
Household income
 Low 1.00 1.00
 Mid-low 0.84 0.55–1.29 0.429 0.76 0.52–1.12 0.170
 Mid-high 1.02 0.65–1.59 0.935 0.87 0.59–1.27 0.458
 High 0.83 0.54–1.29 0.405 0.72 0.48–1.07 0.105
Region
 Urban area 1.00 1.00
 Rural area 1.21 0.82–1.77 0.330 0.84 0.60–1.16 0.281
Occupational categoriesa
 White 0.84 0.57–1.24 0.387 1.16 0.79–1.72 0.455
 Pink 0.97 0.61–1.53 0.894 0.95 0.67–1.34 0.755
 Blue 0.57 0.39–0.81 0.002 1.16 0.81–1.66 0.425
 Inoccupation 1.00 1.00
BMIb
 Underweight or Normal < 25 1.00 1.00
 Overweight ≥ 25.0 2.92 2.19–3.88  < 0.0001 3.87 2.99–5.02  < 0.0001
Drinking status
 No 1.00 1.00
 Yes 1.31 0.92–1.87 0.137 1.08 0.81–1.44 0.619
Walking frequentlyc
 Inadequate 1.00 1.00
 Adequate 0.75 0.59–0.96 0.024 0.83 0.64–1.07 0.143
Energy intake leveld
 Inadequate 1.00 1.00
 Adequate 1.03 0.80–1.34 0.803 0.79 0.62–1.01 0.059
Chronic disease diagnosise
 No 1.00 1.00
 Yes 1.35 0.98–1.86 0.066 1.40 1.01–1.95 0.041
Secondhand smoke exposure
 No 1.00 1.00
 Yes 1.10 0.85–1.42 0.479 0.76 0.56–1.02 0.066
Family historyf
 No 1.00 1.00
 Yes 1.10 0.79–1.53 0.591 1.02 0.76–1.37 0.893
Pack-Year of Smoking
 Pack-Years < 10 1.00 1.00
 10 ≤ Pack-Years < 20 1.14 0.77–1.69 0.242 2.76 1.27–6.01 0.952
  ≥ 20 0.99 0.69–1.41 0.068 0.83 0.27–2.51 0.604
Year
 2016 1.00 1.00
 2017 0.83 0.60–1.14 0.515 0.99 0.73–1.34 0.011
 2018 0.76 0.56–1.02 0.943 0.93 0.69–1.24 0.738
Open in a new tab

IR, insulin resistance; OR, odds ratio; CI, confidence interval.

aThree groups (white, pink, and blue) based on the International Standard Classification of Occupations codes. The inoccupation group includes homemakers.

bBMI: body mass index; obesity status was defined based on BMI according to the 2018 Clinical Practice Guidelines for Overweight and Obesity in Korea.

cWalking frequency was based on the recommended walking activity according to the physical activity guidelines in Korea.

dEnergy intake was classified according to the Korean Nutrient Intake Criteria (2015) provided by the Ministry of Health and Welfare.

eChronic disease was defined as a diagnosed disease, such as hypertension and dyslipidemia.

fFamily history of diabetes was defined as having an immediate family member (e.g., father, mother, brother, and/or sister) with diabetes.

Table 3 presents the results of subgroup analyses stratified by the independent variable. Compared to non-smokers, male participants in the drinking group had an increased risk of insulin resistance in both the continuous-smoker and past-smoker groups (OR = 2.08, 95% CI = 1.53–2.64 and OR = 1.80, 95% CI = 1.23–2.64, respectively); female participants in the drinking group had an increased insulin resistance risk in the continuous-smoker group (OR = 1.98, 95% CI = 1.25–3.13).

Table 3.

Subgroup analysis stratified by independent variables.

Variables High IR
Short-term smoking pattern
Non-smoker Continuous-smoker Past-smoker Current-smoker
OR OR 95% CI p value OR 95% CI p value OR 95% CI p value
Men
BMIa
 Underweight or Normal < 25 1.00 1.84 1.31–2.58 0.001 1.35 0.89–2.03 0.153 2.11 0.28–15.92 0.469
 Overweight ≥ 25.0 1.00 2.23 1.33–3.76 0.003 2.08 1.15–3.76 0.015 2.06 0.20–21.33 0.544
Drinking status
 No 1.00 2.10 0.83–5.31 0.117 0.94 0.42–2.12 0.878 – – –
 Yes 1.00 2.08 1.53–2.64  < 0.0001 1.80 1.23–2.64 0.003 1.68 0.32–8.80 0.541
Walking frequentlyb
 Inadequate 1.00 2.42 1.55–3.79 0.001 1.34 0.83–2.16 0.229 4.61 0.38–56.11 0.229
 Adequate 1.00 1.76 1.19–2.59 0.004 1.79 1.12–2.87 0.015 1.38 0.34–5.70 0.653
Energy intake levelc
 Inadequate 1.00 1.88 1.26–2.80 0.002 1.30 0.85–2.00 0.221 1.32 0.30–5.74 0.709
 Adequate 1.00 2.10 1.33–3.32 0.001 2.21 1.28–3.83 0.004 4.85 0.33–70.71 0.247
Women
BMIa
 Underweight or Normal < 25 1.00 1.70 1.02–2.82 0.040 1.42 0.99–2.03 0.058 1.34 0.35–5.18 0.671
 Overweight ≥ 25.0 1.00 2.03 0.86–4.78 0.106 1.01 0.61–1.69 0.963 2.33 0.42–13.00 0.333
Drinking status
 No 1.00 0.66 0.24–1.78 0.410 1.35 0.84–2.17 0.214 0.59 0.14–2.40 0.455
 Yes 1.00 1.98 1.25–3.13 0.004 1.36 0.95–1.97 0.097 3.25 0.92–11.52 0.067
Walking frequentlyb
 Inadequate 1.00 2.26 1.13–4.51 0.021 1.33 0.89–1.98 0.162 1.81 0.56–5.90 0.324
 Adequate 1.00 1.58 0.93–2.67 0.088 1.26 0.81–1.96 0.301 0.84 0.08–8.75 0.884
Energy intake levelc
 Inadequate 1.00 1.62 0.99–2.66 0.053 1.13 0.80–1.58 0.489 1.45 0.39–5.41 0.581
 Adequate 1.00 1.91 0.85–4.30 0.119 1.77 1.05–2.98 0.032 2.35 0.40–13.81 0.344
Open in a new tab

IR, insulin resistance; OR, odds ratio; CI, confidence interval.

aBMI: body mass index; obesity status was defined based on BMI according to the 2018 Clinical Practice Guidelines for Overweight and Obesity in Korea.

bWalking frequency was based on the recommended walking activity according to the physical activity guidelines in Korea.

cEnergy intake was classified according to the Korean Nutrient Intake Criteria (2015) provided by the Ministry of Health and Welfare.

Obesity affected the risk of insulin resistance in male continuous-smokers and past-smokers (OR = 2.23, 95% CI = 1.33–3.76 and OR = 2.08, 95% CI = 1.15–3.76, respectively). Among women, relative to participants with normal weight, underweight participants who were continuous-smokers had the highest risk of insulin resistance (OR = 1.70, 95% CI = 1.02–2.82). Additionally, the risk of insulin resistance was the highest in the continuous-smoker group among men who rarely walked (OR = 2.42, 95% CI = 1.55–3.79) and among women who walked sufficiently (OR = 2.26, 95% CI = 1.13–4.51). Relative to non-smokers, male continuous-smokers and past-smokers with adequate energy intakes had an increased risk of insulin resistance (OR = 2.10, 95% CI = 1.33–3.32 and OR = 1.79, 95% CI = 1.12–2.87, respectively); for women, this association was observed in the past-smoker group (OR = 1.77, 95% CI = 1.05–2.98).

Discussion

Several previous studies have examined the relationship between smoking and insulin resistance using self-reported data; however, studies on this relationship using biomarkers remain rare. Therefore, this study is one of the few studies to investigate the relationship between smoking patterns and insulin resistance using biomarkers.

Our study found that NNAL and cotinine concentrations in short-term smoking patterns were associated with insulin resistance risk in continuous- and past-smokers who met the smoking criteria. We also found that continuous smoking was significantly associated with the highest risk of insulin resistance in both men and women. However, no association was found between current smokers and insulin resistance; in this group, the smoking criteria were based only on cotinine levels. This suggests that groups with short smoking durations of around 16–20 h could be protected from complications, such as insulin resistance, by applying smoking cessation guidelines and practices.

The findings of the present study are consistent with those of previous studies, despite the use of different data sources13. Furthermore, our findings indirectly support those of prior studies regarding a dose–response relationship between smoking and insulin resistance12,24. Previous studies have shown that the amount and duration of smoking increase the risk of insulin resistance in a dose-dependent manner24. This finding may be due to hormonal changes associated with smoking. Moreover, smoking may induce insulin resistance directly, owing to its effect on abdominal obesity, which may partly occur due to nicotine absorption during smoking9. Another possible mechanism involves the smoking-triggered secretion of hormones such as cortisol, catecholamines, and growth hormones, which oppose the effects of insulin. These hormones increase lipolysis, subsequently increasing free fatty acid release and impairing endothelial function, which may contribute to insulin resistance12. Finally, smoking is negatively associated with adiponectin levels in a dose–response manner25. Therefore, these mechanisms indirectly support the association between continuous and past smoking (representing continuous smoking for > 40 days in our sample) and the risk of insulin resistance.

The stratified subgroup analysis we conducted revealed that continuous-smokers and past-smokers were at an increased risk of insulin resistance; specifically, men with a high body mass index (BMI) had an OR that was more than two-fold higher than that of non-smokers. Previous studies have suggested that smoking may cause insulin resistance by triggering processes associated with fat accumulation in the abdomen and increasing the waist-to-hip circumference ratio9. In addition, an increased body fat percentage has been shown to increase blood levels of non-esterified fatty acids, glycerol, hormones, pro-inflammatory cytokines, and other factors involved in the development of insulin resistance26, suggesting that a high BMI may increase the insulin resistance risk. Additionally, in both male and female participants, continuous-smokers with unhealthy behaviors, such as alcohol intake and lack of exercise, had a more than two-fold higher risk of insulin resistance than their counterparts. This finding supports those from previous studies on the association between unhealthy behaviors, including alcohol consumption and smoking, and serious metabolic abnormalities27, including insulin resistance. Moreover, continuous-smokers and past-smokers with adequate energy intakes had a two-fold higher risk of insulin resistance than their counterparts. In this study, energy intake was stratified into categories defined by the Korean nutrient intake standards28. However, given that smokers consume fewer essential nutrients such as vitamins, calcium, and potassium than non-smokers, it is likely that smokers meet their energy requirements by eating foods that adversely affect insulin resistance29. These findings may account for the increase in the insulin resistance risk that we observed in continuous-smokers and past-smokers. Further studies on the relationships between nutrient intake, smoking, and insulin resistance are required.

This study had several limitations. First, the cross-sectional study design precludes any meaningful conclusions about causality. Second, although we estimated smoking exposure and insulin resistance using urine and blood samples, respectively, data on the remaining variables were obtained from the Korea National Health and Nutrition Examination Survey (KNHANES VII) data, which were based on self-reported information; consequently, some of the estimates used may have been subject to recall bias. Third, participants with type 2 diabetes mellitus were excluded to help control for confounding factors that could affect insulin resistance; nevertheless, this restriction may have obscured or reduced the association between exposure to smoking and the risk of insulin resistance. Fourth, the study sample size was relatively small, specifically the size of the current-smoker group; this limitation was associated with the data source, whereby only half of the total sample was randomly investigated for NNAL and cotinine levels30. However, the KNHANES survey provides data that are nationally representative and inclusive of biomarker information, whereas previous studies did not examine these parameters. Therefore, to support our findings, future studies using larger sample sizes are required.

This study had various strengths. First, this study was based on biomarkers, in contrast to previous studies based on self-reported data. Second, this study utilized nationally representative data from the Republic of Korea, allowing us to evaluate the association between smoking patterns and insulin resistance using high-quality information; the influence of both recall bias and measurement bias on the findings is likely to be small. Finally, some previous studies have used cotinine levels to estimate smoking exposure. Herein, we also included NNAL concentrations; NNAL has a long half-life, contributing to the analysis of smoking patterns.

In conclusion, this study showed that long-term smokers (≥ 40 days) were at an increased risk of insulin resistance in short-term smoking patterns. Our findings regarding short-term smokers (16–20 h) suggest that smoking cessation may protect against complications such as insulin resistance. Therefore, there is a need to educate first-time smokers about the health benefits of quitting smoking.

Methods

This study was based on data collected by the 2016–2018 KNHANES VII. The KNHANES comprises three parts: health surveys, health check-ups including laboratory tests, and nutrition surveys. The KNHANES is a nationwide population-based cross-sectional survey that has been conducted annually since 1998, under the direction of the Korea Centers for Disease Control and Prevention (KCDC) of the Ministry of Health and Welfare, to accurately assess the population’s health and nutritional status31. The KNHANES was approved by the Institutional Review Board of the KCDC, and written informed consent was obtained from all survey participants. This study adhered to the doctrine of the Declaration of Helsinki for Biomedical Research.

The total number of respondents during 2016–2018 was 24,269. As the KNHANES does not evaluate smoking behavior in participants younger than 19 years, data on this age group were excluded (N = 4880). In addition, we excluded participants with diabetes mellitus and those who were either menstruating or pregnant at the time of data collection (N = 4886). Finally, participants with missing values for NNAL, cotinine, and other independent variables were excluded (N = 10,460). Thus, a total of 4043 participants (2067 men and 1976 women) were evaluated (Fig. 1).

Figure 1.

Figure 1

Open in a new tab

Schematic diagram of the study eligibility.

Variables

The dependent variable in this study was the TyG index, a product of fasting triglyceride and glucose blood levels, which helps assess insulin resistance32. In the KNHANES data, fasting (starting after 7 p.m. the day before the survey) blood samples were provided for testing. The TyG index was calculated using the formula, ln(triglyceride [mg/dL] × fasting blood glucose [mg/dL]/2), and expressed on a logarithmic scale5.

We defined short-term smoking patterns by measuring the concentrations of NNAL and cotinine. Spot urinary samples were collected for urinary NNAL and cotinine at the time of health checkup. Urine cotinine was examined in all subjects aged 6 years and above at the health checkup, and NNAL was randomized in half of the health checkup subjects30. Fresh urine samples were collected and immediately underwent routine urinalysis, and the remaining aliquots were stored at –20 °C until the analysis of cotinine and NNAL33. Urine concentrations of cotinine and total NNAL (free NNAL plus NNAL-glucuronide) were analyzed by liquid chromatography-tandem mass spectrometry (LC–MS/MS) using Agilent 1100 Series API 4000 (AB Sciex, Foster City, CA, USA) and Agilent 1200 Series Triple Quadrupole 5500 (AB Sciex, Foster City, CA, USA), respectively34,35. The limit of detection was 0.27399 ng/mL for cotinine and 0.1006 pg/mL for NNAL30,36.

In this study, NNAL and cotinine concentrations were used to classify the participants into smoking and non-smoking groups using the smoking concentration standards of the KCDC (2.13 pg/mL and 50 ng/mL for NNAL and cotinine, respectively)37. We defined “short-term smoking pattern” based on half-life values (i.e. 18–24 h, 40 days for cotinine and NNAL)23,38. A "Continuous smoker" was defined as a participant who met both smoking criteria for 18–24 h and 40 days. Thus, both NNAL and cotinine concentrations are participants who meet smoking criteria. "Current-smokers" were defined as those who did not meet the 40 days smoking criteria but met the 18–24 h smoking criteria. Therefore, participants who did not meet the NNAL smoking concentrations criteria but did meet the Cotinine smoking concentrations criteria. "Past-smokers" were defined as those who met the 40 days smoking criteria but not the 18–24 h smoking criteria. Therefore, participants who meet the NNAL smoking concentrations criteria but not the cotinine smoking concentrations criteria. "Non-smoker" was defined as a person who did not meet both smoking criteria for 18–24 h and 40 days. Therefore, both NNAL and cotinine concentrations do not meet the smoking criteria (Fig. S1).

Potential confounding variables included sociodemographic and health-related characteristics and the study year. Sociodemographic characteristics included age, marital status, educational level, household income, region, and occupation. Health-related characteristics included BMI, drinking status, walking frequency, energy intake level, chronic disease diagnosis, secondhand smoking exposure, family history of diabetes, and pack-year estimates.

Statistical analyses

Before the analysis, we excluded cases where there was no response to the variables required for the study (Fig. 1). Therefore, in this study, all estimates were calculated using sample weights assigned to the study participants. The sample weights were constructed by the KNHANES to represent the population in the Republic of Korea while accounting for the complex survey design and survey non-response31. Additionally, we performed a pre-analysis to classify participants into “low” and “high” insulin resistance groups. We analyzed the TyG index using receiver operating characteristic curves to estimate valid cut-off values for impaired fasting glucose levels, and the effective cut-off values for the TyG index were 8.3878 and 8.60248 for men and women, respectively; these were similar to previously reported values39 and were used in this study. A univariate linear regression analysis was conducted to investigate the general characteristics of the study population. Multiple regression analyses were performed and adjusted for covariates to analyze the association between smoking patterns and insulin resistance. Further, subgroup analyses were performed with multiple linear regression models stratified by sex to investigate the associations of BMI, drinking status, walking frequency, and energy intake levels with insulin resistance. ORs and 95% CIs were calculated to compare non-smokers to continuous-smokers, current-smokers, and past-smokers. All statistical analyses were performed using SAS software version 9.4 (SAS Institute, Inc., Cary, NC, USA). Findings were considered significant at P values  < 0.05.

Supplementary Information

Supplementary Information. (43.7KB, docx)

Acknowledgements

We wish to thank the Korea Centers for Disease Control and Prevention for providing data from the Korea National Health and Nutrition Examination Survey. In addition, we would like to thank our colleagues at the Institute of Health Services Research of Yonsei University, who provided their advice on intellectual content.

Author contributions

S.-I.J., S.H.C. and S.H.J. designed the study, collected the data, performed the statistical analysis, and drafted the manuscript. S.H.C., S.H.J., J.Y.S., S.H.P., and S-I.J. contributed to the discussion, as well as reviewed and edited the manuscript. S-I.J. is the guarantor of this work, and as such, has full access to all study data. S-I.J. assumes responsibility for the integrity of the data and the accuracy of the data analysis. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI20C1130).

Data availability

The datasets generated or analyzed during the current study (Korea National Health and Nutrition Examination Survey 2016–2018) are available at https://knhanes.kdca.go.kr/knhanes/eng/index.do.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Soo Hyeon Cho and Sung Hoon Jeong.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-022-07626-1.

References

  • 1.Bessesen DH. The role of carbohydrates in insulin resistance. J. Nutr. 2001;131:2782S–2786S. doi: 10.1093/jn/131.10.2782S. [DOI] [PubMed] [Google Scholar]
  • 2.DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am. J. Physiol. Endocrinol. Metab. 1979;237:E214. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  • 3.Morris AD, et al. The euglycaemic hyperinsulinaemic clamp: An evaluation of current methodology. Clin. Exp. Pharmacol. Physiol. 1997;24:513–518. doi: 10.1111/j.1440-1681.1997.tb01237.x. [DOI] [PubMed] [Google Scholar]
  • 4.Bonora E, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63. doi: 10.2337/diacare.23.1.57. [DOI] [PubMed] [Google Scholar]
  • 5.Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab. Syndr. Relat. Disord. 2008;6:299–304. doi: 10.1089/met.2008.0034. [DOI] [PubMed] [Google Scholar]
  • 6.Lee S-H, et al. Predicting the development of diabetes using the product of triglycerides and glucose: The Chungju Metabolic Disease Cohort (CMC) study. PLoS One. 2014;9:e90430. doi: 10.1371/journal.pone.0090430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kim MK, et al. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc. Diabetol. 2017;16:1–7. doi: 10.1186/s12933-016-0482-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lee SB, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc. Diabetol. 2018;17:1–6. doi: 10.1186/s12933-017-0656-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Artese A, Stamford BA, Moffatt RJ. Cigarette smoking: An accessory to the development of insulin resistance. Am. J. Lifestyle Med. 2019;13:602–605. doi: 10.1177/1559827617726516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Foy CG, Bell RA, Farmer DF, Goff DC, Wagenknecht LE. Smoking and incidence of diabetes among US adults: Findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2005;28:2501–2507. doi: 10.2337/diacare.28.10.2501. [DOI] [PubMed] [Google Scholar]
  • 11.Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24:1590–1595. doi: 10.2337/diacare.24.9.1590. [DOI] [PubMed] [Google Scholar]
  • 12.Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind. Health. 2005;43:295–301. doi: 10.2486/indhealth.43.295. [DOI] [PubMed] [Google Scholar]
  • 13.Sun K, Liu J, Ning G. Active smoking and risk of metabolic syndrome: A meta-analysis of prospective studies. PloS One. 2012;7:e47791. doi: 10.1371/journal.pone.0047791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wilcox R, Hughes J, Roland J. Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br. Med. J. 1979;2:1026–1028. doi: 10.1136/bmj.2.6197.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Klebanoff MA, Levine RJ, Clemens JD, DerSimonian R, Wilkins DG. Serum cotinine concentration and self-reported smoking during pregnancy. Am. J. Epidemiol. 1998;148:259–262. doi: 10.1093/oxfordjournals.aje.a009633. [DOI] [PubMed] [Google Scholar]
  • 16.Oh H-Y, Paek Y-J. The biomarkers of active and passive smoke exposure. J. Korean Soc. Res. Nicot. Tob. 2011;2:79–88. doi: 10.25055/JKSRNT.2011.2.2.79. [DOI] [Google Scholar]
  • 17.Haley NJ, Axelrad CM, Tilton KA. Validation of self-reported smoking behavior: Biochemical analyses of cotinine and thiocyanate. Am. J. Public Health. 1983;73:1204–1207. doi: 10.2105/AJPH.73.10.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: A minireview. Int. Arch. Occup. Environ. Health. 1998;71:162–168. doi: 10.1007/s004200050266. [DOI] [PubMed] [Google Scholar]
  • 19.Kim BJ, et al. Relationship of cotinine-verified and self-reported smoking status with metabolic syndrome in 116,094 Korean adults. J. Clin. Lipidol. 2017;11:638–645. e632. doi: 10.1016/j.jacl.2017.03.011. [DOI] [PubMed] [Google Scholar]
  • 20.Park EY, Lim MK, Park E, Oh J-K, Lee D-H. Relationship Between urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and lung cancer risk in the general population: A community-based Prospective Cohort Study. Front. Oncol. 2021;11:493. doi: 10.3389/fonc.2021.611674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hecht SS, et al. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J. Natl. Cancer Inst. 2004;96:107–115. doi: 10.1093/jnci/djh016. [DOI] [PubMed] [Google Scholar]
  • 22.Xia Y, Bernert JT, Jain RB, Ashley DL, Pirkle JL. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007–2008. Biomarkers. 2011;16:112–119. doi: 10.3109/1354750X.2010.533288. [DOI] [PubMed] [Google Scholar]
  • 23.Benowitz NL, et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicot. Tob. Res. 2020;22:1086–1097. doi: 10.1093/ntr/ntz132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Oh JE. Association between smoking status and metabolic syndrome in men. Korean J. Obes. 2014;23:99–105. doi: 10.7570/kjo.2014.23.2.99. [DOI] [Google Scholar]
  • 25.Kawamoto R, et al. Smoking status is associated with serum high molecular adiponectin levels in community-dwelling Japanese men. J. Atheroscler. Thromb. 2010;17:423–430. doi: 10.5551/jat.3681. [DOI] [PubMed] [Google Scholar]
  • 26.Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–846. doi: 10.1038/nature05482. [DOI] [PubMed] [Google Scholar]
  • 27.Park SH. Smoking-related differential influence of alcohol consumption on the metabolic syndrome. Subst. Use Misuse. 2019;54:2351–2358. doi: 10.1080/10826084.2019.1648515. [DOI] [PubMed] [Google Scholar]
  • 28.Korea Ministry of Health and Welfare. The Korean Nutrition Society. Dietary reference intakes for Koreans 2015. (Sejong, 2015).
  • 29.McKeown NM, et al. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care. 2004;27:538–546. doi: 10.2337/diacare.27.2.538. [DOI] [PubMed] [Google Scholar]
  • 30.Korea Centers for Disease Control and Prevention . The seventh Korea National Health and Nutrition Examination Survey 2016–2018(KNHANES) Sejong: Korea Ministry of Health and Welfare; 2020. [Google Scholar]
  • 31.Kweon S, et al. Data resource profile: The Korea national health and nutrition examination survey (KNHANES) Int. J. Epidemiol. 2014;43:69–77. doi: 10.1093/ije/dyt228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Guerrero-Romero F, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J. Clin. Endocrinol Metab. 2010;95:3347–3351. doi: 10.1210/jc.2010-0288. [DOI] [PubMed] [Google Scholar]
  • 33.Choi JW, Fujii T, Fujii N. Association of a tobacco-specific nitrosamine carcinogen with urinary cotinine, urinary sodium excretion, and total energy intake in adolescents and children. Curr. Med. Sci. 2021;41:270–278. doi: 10.1007/s11596-021-2343-0. [DOI] [PubMed] [Google Scholar]
  • 34.Vardavas CI, et al. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations. Tob. Control. 2013;22:194–200. doi: 10.1136/tobaccocontrol-2011-050144. [DOI] [PubMed] [Google Scholar]
  • 35.Stiby A, et al. Association of maternal smoking with child cotinine levels. Nicot. Tob. Res. 2013;15:2029–2036. doi: 10.1093/ntr/ntt094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Krishnamoorthy K, Mallick A, Mathew T. Model-based imputation approach for data analysis in the presence of non-detects. Ann. Occup. Hyg. 2009;53:249–263. doi: 10.1093/annhyg/men083. [DOI] [PubMed] [Google Scholar]
  • 37.Korea Ministry of Health and Welfare. Development of National Biomonitoring Program for Exposure to Tobacco Smoke (2016).
  • 38.Gutiérrez-Torres DS, et al. Concentrations of cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in US non-daily cigarette smokers. Cancer Epidemiol. Prev. Biomark. 2021;30:1165–1174. doi: 10.1158/1055-9965.EPI-20-1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jeong SH, Joo HJ, Kwon J, Park E-C. Association between smoking behavior and insulin resistance using triglyceride-glucose index among South Korean adults. J. Clin. Endocrinol. Metab. 2021;160:e4531–e4541. doi: 10.1210/clinem/dgab399. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information. (43.7KB, docx)

Data Availability Statement

The datasets generated or analyzed during the current study (Korea National Health and Nutrition Examination Survey 2016–2018) are available at https://knhanes.kdca.go.kr/knhanes/eng/index.do.

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES